Form Type: 4

SEC EDGAR Link
Accession Number:0001759655-23-000040
Date:2023-03-09
Issuer: PRIVIA HEALTH GROUP, INC. (PRVA)
Original Submission Date:

Reporting Person:

MEHROTRA PARTH
PRIVIA HEALTH GROUP, INC.
950 N. GLEBE RD., SUITE 700 ARLINGTON, VA 22203

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.01 PAR VALUE PER SHARE 2023-03-09 M 20,101 a $2.00 117,492 direct
COMMON STOCK, $0.01 PAR VALUE PER SHARE 2023-03-09 S 20,101 d $28.30 97,391 direct
COMMON STOCK, $0.01 PAR VALUE PER SHARE 2023-03-10 M 70 a $2.00 97,461 direct
COMMON STOCK, $0.01 PAR VALUE PER SHARE 2023-03-10 M 200 a $2.00 97,661 direct
COMMON STOCK, $0.01 PAR VALUE PER SHARE 2023-03-10 S 270 d $28.22 97,391 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO PURCHASE) 2.0 2023-03-09 deemed execution date M 20,101 (d) 2033-08-27 common stock 20,101 $2.00 280,516 direct
STOCK OPTION (RIGHT TO PURCHASE) 2.0 2023-03-10 deemed execution date M 70 (d) 2033-08-27 common stock 70 $2.00 280,446 direct
STOCK OPTION (RIGHT TO PURCHASE) 2.0 2023-03-10 deemed execution date M 200 (d) 2034-12-04 common stock 200 $2.00 272,377 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on august 15, 2022.
f2 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $28.00 to $28.64 per share. the reporting person undertakes to provide to privia health group, inc., any security holder of privia health group, inc. or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
f3 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $28.08 to $28.39 per share. the reporting person undertakes to provide to privia health group, inc., any security holder of privia health group, inc. or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
f4 all stock options are fully vested and exercisable.
WhaleWisdom Logo

Elevate your investments